The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Lymphoma, Small-Cell

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lymphoma, Small-Cell


High impact information on Lymphoma, Small-Cell


Chemical compound and disease context of Lymphoma, Small-Cell


Biological context of Lymphoma, Small-Cell


Anatomical context of Lymphoma, Small-Cell


Gene context of Lymphoma, Small-Cell


Analytical, diagnostic and therapeutic context of Lymphoma, Small-Cell


  1. The American Burkitt Lymphoma Registry: a progress report. Levine, P.H., Connelly, R.R., Berard, C.W., O'Connor, G.T., Dorfman, R.F., EASTON, J.M., DeVita, V.T. Ann. Intern. Med. (1975) [Pubmed]
  2. Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Ritz, J., Nadler, L.M., Bhan, A.K., Notis-McConarty, J., Pesando, J.M., Schlossman, S.F. Blood (1981) [Pubmed]
  3. Transmembrane adaptor molecules: a new category of lymphoid-cell markers. Tedoldi, S., Paterson, J.C., Hansmann, M.L., Natkunam, Y., Rüdiger, T., Angelisova, P., Du, M.Q., Roberton, H., Roncador, G., Sanchez, L., Pozzobon, M., Masir, N., Barry, R., Pileri, S., Mason, D.Y., Marafioti, T., Horejsí, V. Blood (2006) [Pubmed]
  4. Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Rimokh, R., Berger, F., Delsol, G., Charrin, C., Berthéas, M.F., Ffrench, M., Garoscio, M., Felman, P., Coiffier, B., Bryon, P.A. Blood (1993) [Pubmed]
  5. Thymidine kinase isoenzymes in human malignant lymphoma. Ellims, P.H., Van der Weyden, M.B., Medley, G. Cancer Res. (1981) [Pubmed]
  6. Identification of partial complementary DNA clones encoding a 59-kd protein with characteristics of a unique oncofetal antigen. Rashid, H.U., Barsoum, A.L., Cao, T.M., Coggin, J.H. J. Natl. Cancer Inst. (1994) [Pubmed]
  7. Immunologic abnormalities in patients with malignant lymphoproliferative diseases. Hunter, C.P., Tannenbaum, H., Churchill, W.H., Moloney, W.C., Schur, P.H. J. Natl. Cancer Inst. (1977) [Pubmed]
  8. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Chahinian, A.P., Pajak, T.F., Holland, J.F., Norton, L., Ambinder, R.M., Mandel, E.M. Ann. Intern. Med. (1982) [Pubmed]
  9. Estrogen receptors and lymphocytic lymphoma. Morgan, D. Ann. Intern. Med. (1981) [Pubmed]
  10. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Jones, D., Benjamin, R.J., Shahsafaei, A., Dorfman, D.M. Blood (2000) [Pubmed]
  11. Inhalation toxicology and carcinogenicity of 1,3-butadiene in B6C3F1 mice following 65 weeks of exposure. Melnick, R.L., Huff, J.E., Roycroft, J.H., Chou, B.J., Miller, R.A. Environ. Health Perspect. (1990) [Pubmed]
  12. Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia. Zinzani, P.L., Bendandi, M., Magagnoli, M., Albertini, P., Rondelli, D., Stefoni, V., Tani, M., Tura, S. Haematologica (2000) [Pubmed]
  13. The use of azathiaprine and 6-mercaptopurine (6-MP) as immunosuppressive therapy in inflammatory bowel disease and its role in the etiology of lymphocytic lymphoma. Gelb, A., Zalusky, R. Am. J. Gastroenterol. (1983) [Pubmed]
  14. Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma. Dumontet, C., Morschhauser, F., Solal-Celigny, P., Bouafia, F., Bourgeois, E., Thieblemont, C., Leleu, X., Hequet, O., Salles, G., Coiffier, B. Br. J. Haematol. (2001) [Pubmed]
  15. Development of a lymphocytic lymphoma during immunosuppressive therapy with azathioprine for systemic lupus erythematosus with renal involvement induced by phenylbutazone. Walden, P.A., Philalithis, P.E., Joekes, A.M., Bagshawe, K.D. Clin. Nephrol. (1977) [Pubmed]
  16. Comparison of morphologic features and mitotic rate to cytometrically determined DNA content of poorly differentiated lymphocytic lymphomas. Palutke, M., Schnitzer, B., Dresner, D., Tabaczka, P., Ratanatharathorn, V., Eisenberg, L., Tenenbaum, D. Ann. N. Y. Acad. Sci. (1986) [Pubmed]
  17. Podophyllum hexandrum (Himalayan mayapple) extract provides radioprotection by modulating the expression of proteins associated with apoptosis. Kumar, R., Singh, P.K., Sharma, A., Prasad, J., Sagar, R., Singh, S., Arora, R., Sharma, R.K. Biotechnol. Appl. Biochem. (2005) [Pubmed]
  18. Conversion of a benign lymphoepithelial salivary gland lesion to lymphocytic lymphoma during dilantin therapy: correlation with dilantin-induced lymphocyte transformation in vitro. Lapes, M., Antoniades, K., Gartner, W., Vivacqua, R. Cancer (1976) [Pubmed]
  19. Human malignant lymphomas in vitro. Characterization of biopsy cells and establishment of permanent cell lines. Sundström, C., Nilsson, K. Acta pathologica et microbiologica Scandinavica. Section A, Pathology. (1978) [Pubmed]
  20. Bone marrow amyloid in patients with M-component. Tosato, G., Fagiolo, E. Tumori. (1977) [Pubmed]
  21. Purification and partial characterization of 200 kDa oncofetal antigen from radiation induced murine lymphocytic lymphoma. Barsoum, A.L., Coggin, J.H. Int. J. Biochem. (1993) [Pubmed]
  22. Biology of the lymphomas: cytogenetics, molecular biology, and virology. Ambinder, R.F., Griffin, C.A. Current opinion in oncology. (1991) [Pubmed]
  23. Break in the BCL1 locus is closely associated with intermediate lymphocytic lymphoma subtype. Rimokh, R., Berger, F., Cornillet, P., Wahbi, K., Rouault, J.P., Ffrench, M., Bryon, P.A., Gadoux, M., Gentilhomme, O., Germain, D. Genes Chromosomes Cancer (1990) [Pubmed]
  24. t(18;22)(q21;q11) with rearrangement of BCL2 as a possible secondary change in a lymphocytic lymphoma. Leroux, D., Hillion, J., Monteil, M., Le Marc'hadour, F., Jacob, M.C., Sotto, J.J., Larsen, C.J. Genes Chromosomes Cancer (1991) [Pubmed]
  25. Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma? Leroux, D., Le Marc'Hadour, F., Gressin, R., Jacob, M.C., Keddari, E., Monteil, M., Caillot, P., Jalbert, P., Sotto, J.J. Br. J. Haematol. (1991) [Pubmed]
  26. Immunologic surface markers in non-Hodgkin's lymphomas. Cossman, J., Schnitzer, B., Deegan, M.J. Am. J. Pathol. (1977) [Pubmed]
  27. The nephrotic syndrome associated with neoplasia: an unusual paraneoplastic syndrome. Report of a case and review of the literature. Gagliano, R.G., Costanzi, J.J., Beathard, G.A., Sarles, H.E., Bell, J.D. Am. J. Med. (1976) [Pubmed]
  28. Chronic lymphocytic leukaemia: case control epidemiological study in Yorkshire. Cartwright, R.A., Bernard, S.M., Bird, C.C., Darwin, C.M., O'Brien, C., Richards, I.D., Roberts, B., McKinney, P.A. Br. J. Cancer (1987) [Pubmed]
  29. 5-year survey of methotrexate, cyclophosphamide (Endoxan), and vincristine (MEV) therapy for advanced non-Hodgkin's lymphomas. Lauria, F., Baccarani, M., Fiacchini, M., Frezza, R., Gobbi, M., Tura, S. Cancer treatment reports. (1978) [Pubmed]
WikiGenes - Universities